We say farewell to Usman who is attending the University of Rochester for an MD-PhD program. Best wishes to you in your future endeavors – we will miss you!
The return of the 9th Annual Lungstrong 5K as a live and in person event was a success – thanks to everyone who came out to run and walk in support of lung cancer research at MGH!
Toshio joined the Hata Lab in April 2022. He received his MD at Nagoya City University, Japan and practiced as a thoracic surgeon in Japan, where he developed a great interest in cancer biology. He then obtained his Ph.D. at Kindai University, Japan, where he studied the resistance mechanism to MET-TKIs in lung cancer harboring MET exon 14 skipping mutation in the laboratory of Dr. Tetsuya Mitsudomi. Toshio is currently focusing on drug persister cancer cell and acquired resistance to targeted therapies especially in ALK-positive lung cancer. Despite of the initial drastic efficacy of molecular targeted therapy, all patients inevitably develop resistance. Toshio believes that his project will contribute to establish new treatment strategies for lung cancer to prevent the drug resistance.
We say farewell to Linh who is a MD-PhD Candidate at Thomas Jefferson University. Best wishes to you in your future endeavors – we will miss you!